• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染可调节与DNA错配修复途径相关的微小RNA的表达。

Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway.

作者信息

Santos Juliana C, Brianti Mitsue T, Almeida Victor R, Ortega Manoela M, Fischer Wolfgang, Haas Rainer, Matheu Ander, Ribeiro Marcelo L

机构信息

Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, São Francisco University, Bragança Paulista, São Paulo, Brazil.

Women's Integrated Healthcare Center (CAISM), State University of Campinas, (UNICAMP) Campinas, São Paulo, Brazil.

出版信息

Mol Carcinog. 2017 Apr;56(4):1372-1379. doi: 10.1002/mc.22590. Epub 2016 Nov 23.

DOI:10.1002/mc.22590
PMID:27862371
Abstract

Genetic and epigenetic inactivation of DNA mismatch repair (MMR) genes might lead to modifications in cancer-related gene expression and cancer development. Recently, it has been shown that the infection by Helicobacter pylori, the major causative agent of gastric cancer, induces DNA damage and inhibits MMR DNA repair. Also, it has been reported that microRNAs (miRs) have an important role in regulating genomic stability and MMR DNA repair. Thus, the aim of this study was to identify miRs regulating MMR pathway in H. pylori-associated gastric carcinogenesis. To address this question, a gastric epithelial cell line and AGS cancer gastric cells were infected with several H. pylori strains. MMR gene expression and miRs correlating with H. pylori strain infection were evaluated. The results showed that H. pylori infection significantly down-regulated the expression of all selected MMR genes. Also, H. pylori infection modulated the expression of several miRs (including miR-150-5p, miR-155-5p, and miR-3163), after 4, 8, and 12 h of infection. Computational prediction of candidate miRs and their predicted MMR targeting sites were obtained from TargetScan, mirDB, and MetaCore. The generated data indicated that the selected miRs (miR-150-5p, miR-155-5p, and miR-3163) could possibly target and modulate MMR genes (POLD3, MSH2, and MSH3, respectively). The target validation was performed using mimics and luciferase gene reporter assays. Briefly, this study shows that H. pylori impairs MMR DNA repair pathway and identifies miRs that regulate MMR gene expression in gastric cancer. © 2016 Wiley Periodicals, Inc.

摘要

DNA错配修复(MMR)基因的遗传和表观遗传失活可能导致癌症相关基因表达的改变以及癌症的发生发展。最近的研究表明,胃癌的主要致病因子幽门螺杆菌感染可诱导DNA损伤并抑制MMR DNA修复。此外,有报道称微小RNA(miRs)在调节基因组稳定性和MMR DNA修复中起重要作用。因此,本研究的目的是鉴定在幽门螺杆菌相关胃癌发生过程中调节MMR途径的miRs。为了解决这个问题,用几种幽门螺杆菌菌株感染了胃上皮细胞系和AGS胃癌细胞。评估了与幽门螺杆菌菌株感染相关的MMR基因表达和miRs。结果表明,幽门螺杆菌感染显著下调了所有选定MMR基因的表达。此外,在感染4、8和12小时后,幽门螺杆菌感染调节了几种miRs(包括miR-150-5p、miR-155-5p和miR-3163)的表达。从TargetScan、mirDB和MetaCore获得候选miRs及其预测的MMR靶向位点的计算预测结果。生成的数据表明,选定的miRs(miR-150-5p、miR-155-5p和miR-3163)可能分别靶向并调节MMR基因(POLD3、MSH2和MSH3)。使用模拟物和荧光素酶基因报告试验进行了靶点验证。简而言之,本研究表明幽门螺杆菌损害MMR DNA修复途径,并鉴定了在胃癌中调节MMR基因表达的miRs。©2016威利期刊公司。

相似文献

1
Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway.幽门螺杆菌感染可调节与DNA错配修复途径相关的微小RNA的表达。
Mol Carcinog. 2017 Apr;56(4):1372-1379. doi: 10.1002/mc.22590. Epub 2016 Nov 23.
2
Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells.幽门螺杆菌感染会诱发胃细胞中核DNA和线粒体DNA的基因不稳定。
Clin Cancer Res. 2009 May 1;15(9):2995-3002. doi: 10.1158/1078-0432.CCR-08-2686. Epub 2009 Apr 21.
3
Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.miRNA-218 表达降低与胃癌中核因子 κB 的高激活有关。
Cancer. 2010 Jan 1;116(1):41-9. doi: 10.1002/cncr.24743.
4
MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6.幽门螺杆菌感染下调 miR-1298-5p 水平,通过靶向 MAP2K6 抑制自噬,促进胃癌发生。
Cell Signal. 2022 May;93:110286. doi: 10.1016/j.cellsig.2022.110286. Epub 2022 Feb 19.
5
Helicobacter pylori-Mediated Genetic Instability and Gastric Carcinogenesis.幽门螺杆菌介导的基因不稳定与胃癌发生
Curr Top Microbiol Immunol. 2017;400:305-323. doi: 10.1007/978-3-319-50520-6_13.
6
Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer.miR-146a 的下调促进了幽门螺杆菌阴性胃癌细胞的迁移。
J Cell Biochem. 2019 Jun;120(6):9495-9505. doi: 10.1002/jcb.28225. Epub 2018 Dec 9.
7
Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.幽门螺杆菌诱导的 miR-135b-5p 促进胃癌对顺铂耐药。
FASEB J. 2019 Jan;33(1):264-274. doi: 10.1096/fj.201701456RR. Epub 2018 Jul 9.
8
MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.微小RNA-143-3p在幽门螺杆菌阳性胃癌中上调,通过直接靶向AKT2抑制肿瘤生长、迁移和侵袭。
Oncotarget. 2017 Apr 25;8(17):28711-28724. doi: 10.18632/oncotarget.15646.
9
MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.microRNA-320a 和 microRNA-4496 通过靶向β-连环蛋白和 ATP 结合盒,亚家族 G,成员 2 来减轻幽门螺杆菌细胞毒素相关基因 A(CagA)诱导的癌症起始潜能和化学耐药性。
J Pathol. 2017 Apr;241(5):614-625. doi: 10.1002/path.4866. Epub 2017 Feb 17.
10
CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.CagA 通过表观遗传调控减弱幽门螺杆菌相关致癌作用中的 let-7 表达。
Gut. 2013 Nov;62(11):1536-46. doi: 10.1136/gutjnl-2011-301625. Epub 2012 Aug 30.

引用本文的文献

1
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials.基于纳米材料的癌症治疗中靶向肿瘤微生物群
Exploration (Beijing). 2025 Mar 24;5(4):e20210185. doi: 10.1002/EXP.20210185. eCollection 2025 Aug.
2
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群:机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
3
Microbiota and gastric cancer: from molecular mechanisms to therapeutic strategies.微生物群与胃癌:从分子机制到治疗策略
Front Cell Infect Microbiol. 2025 Jun 3;15:1563061. doi: 10.3389/fcimb.2025.1563061. eCollection 2025.
4
Gut microbiota in cancer initiation, development and therapy.肠道微生物群在癌症的起始、发展和治疗中的作用
Sci China Life Sci. 2024 Dec 30. doi: 10.1007/s11427-024-2831-x.
5
MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle.微小RNA-155及其外泌体形式:胃肠道癌谜团中的小碎片
Cell Biol Toxicol. 2024 Sep 16;40(1):77. doi: 10.1007/s10565-024-09920-2.
6
Microbiome-Stealth Regulator of Breast Homeostasis and Cancer Metastasis.微生物群——乳腺内环境稳定和癌症转移的隐形调节因子
Cancers (Basel). 2024 Aug 31;16(17):3040. doi: 10.3390/cancers16173040.
7
Intratumoural microbiota: a new frontier in cancer development and therapy.肿瘤内微生物群:癌症发展和治疗的新前沿。
Signal Transduct Target Ther. 2024 Jan 10;9(1):15. doi: 10.1038/s41392-023-01693-0.
8
Microbiota in cancer: molecular mechanisms and therapeutic interventions.癌症中的微生物群:分子机制与治疗干预
MedComm (2020). 2023 Nov 5;4(6):e417. doi: 10.1002/mco2.417. eCollection 2023 Dec.
9
Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.癌症相关微生物群:从疾病致病机制到以微生物群为中心的抗癌方法
Biology (Basel). 2022 May 16;11(5):757. doi: 10.3390/biology11050757.
10
Targeting the gut and tumor microbiota in cancer.靶向癌症中的肠道和肿瘤微生物组。
Nat Med. 2022 Apr;28(4):690-703. doi: 10.1038/s41591-022-01779-2. Epub 2022 Apr 19.